Literature DB >> 15476939

Urocortins as cardiovascular peptides.

Kazuhiro Takahashi1, Kazuhito Totsune, Osamu Murakami, Shigeki Shibahara.   

Abstract

Urocortins (Ucn) 1, 2 and 3, human homologues of fish urotensin I, form the corticotropin-releasing factor (CRF) family, together with CRF, urotensin I and sauvagine. Ucn 3 is a novel member of this family and is a specific ligand for CRF type 2 receptor. CRF type 2 receptor is thought to mediate the stress-coping responses, such as anxiolysis, anorexia, vasodilatation, a positive inotropic action on myocardium and dearousal. Endogenous ligands for the CRF type 2 receptor expressed in the cardiovascular tissues, such as the myocardium, have long been unknown. We have shown expression of Ucn 3 as well as Ucn 1 in the human heart. Ucn 3 is also expressed in the kidney, particularly distal tubules. Studies in various rat tissues showed that high concentrations of immunoreactive Ucn 3 were found in the pituitary gland, adrenal gland, gastrointestinal tract, ovary and spleen in addition to the brain, heart and kidney. These observations suggest that Ucn 3 is expressed in various tissues including heart and kidney, and may regulate the circulation in certain aspects of stress and diseases, such as inflammation. Ucn 1 and 3 appear to have important pathophysiological roles in some cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476939     DOI: 10.1016/j.peptides.2004.04.018

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  Urocortins are present in the rat testis.

Authors:  Soon Lee; Brian Braden; Sang Soo Kang; Catherine Rivier
Journal:  Neuropeptides       Date:  2011-01-21       Impact factor: 3.286

Review 2.  Corticotropin-releasing factor signaling and visceral response to stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Exp Biol Med (Maywood)       Date:  2010-10

3.  Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats.

Authors:  Yasutada Akiba; Jonathan D Kaunitz; Mulugeta Million
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

4.  Urocortins and CRF type 2 receptor isoforms expression in the rat stomach are regulated by endotoxin: role in the modulation of delayed gastric emptying.

Authors:  Pu-Qing Yuan; S Vincent Wu; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-04-19       Impact factor: 4.052

Review 5.  Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.

Authors:  Eva M Fekete; Eric P Zorrilla
Journal:  Front Neuroendocrinol       Date:  2006-11-02       Impact factor: 8.606

6.  Urocortin 2 autocrine/paracrine and pharmacologic effects to activate AMP-activated protein kinase in the heart.

Authors:  Ji Li; Dake Qi; Haiying Cheng; Xiaoyue Hu; Edward J Miller; Xiaohong Wu; Kerry S Russell; Nicole Mikush; Jiasheng Zhang; Lei Xiao; Robert S Sherwin; Lawrence H Young
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

7.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

Review 8.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

Review 9.  Cardioprotective actions of peptide hormones in myocardial ischemia.

Authors:  Dwaine S Burley; Shabaz A Hamid; Gary F Baxter
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

10.  Urocortin in second trimester amniotic fluid: its role as predictor of preterm labor.

Authors:  C Iavazzo; K Tassis; D Gourgiotis; M Boutsikou; S Baka; D Hassiakos; C Vogiatzi; L Florentin-Arar; A Malamitsi-Puchner
Journal:  Mediators Inflamm       Date:  2009-11-04       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.